A citation-based method for searching scientific literature

Abdulaziz B Hamid, Ruben C Petreaca. Cancers (Basel) 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Nanocarriers as an emerging platform for cancer therapy.
Dan Peer, Jeffrey M Karp, Seungpyo Hong, Omid C Farokhzad, Rimona Margalit, Robert Langer. Nat Nanotechnol 2007
50

Targeting Notch to target cancer stem cells.
Antonio Pannuti, Kimberly Foreman, Paola Rizzo, Clodia Osipo, Todd Golde, Barbara Osborne, Lucio Miele. Clin Cancer Res 2010
323
50

Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.
Clément Anfray, Aldo Ummarino, Fernando Torres Andón, Paola Allavena. Cells 2019
69
50

NK cell recognition.
Lewis L Lanier. Annu Rev Immunol 2005
50

Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma.
Terence Kin-Wah Lee, Vincent Chi-Ho Cheung, Ping Lu, Eunice Yuen Ting Lau, Stephanie Ma, Kwan Ho Tang, Man Tong, Jessica Lo, Irene Oi Lin Ng. Hepatology 2014
123
50

Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer.
Jingxian Ding, Wei Jin, Canming Chen, Zhiming Shao, Jiong Wu. PLoS One 2012
69
50

NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.
Ari S Nowacek, Reagan L Miller, Joellyn McMillan, Georgette Kanmogne, Michel Kanmogne, R Lee Mosley, Zhiya Ma, Sabine Graham, Mahesh Chaubal, Jane Werling,[...]. Nanomedicine (Lond) 2009
89
50


Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.
Ping-Ying Pan, Ge Ma, Kaare J Weber, Junko Ozao-Choy, George Wang, Bingjiao Yin, Celia M Divino, Shu-Hsia Chen. Cancer Res 2010
281
50

Stem cells, cancer, and cancer stem cells.
T Reya, S J Morrison, M F Clarke, I L Weissman. Nature 2001
50

Cancer stem cells in glioblastoma.
Justin D Lathia, Stephen C Mack, Erin E Mulkearns-Hubert, Claudia L L Valentim, Jeremy N Rich. Genes Dev 2015
734
50

Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.
C Raggi, H S Mousa, M Correnti, A Sica, P Invernizzi. Oncogene 2016
85
50

Optimizing size and copy number for PEG-fMLF (N-formyl-methionyl-leucyl-phenylalanine) nanocarrier uptake by macrophages.
Li Wan, Xiaoping Zhang, Shahriar Pooyan, Matthew S Palombo, Michael J Leibowitz, Stanley Stein, Patrick J Sinko. Bioconjug Chem 2008
27
50

Cancer stem cell targeted therapy: progress amid controversies.
Tao Wang, Sarah Shigdar, Michael P Gantier, Yingchun Hou, Li Wang, Yong Li, Hadi Al Shamaileh, Wang Yin, Shu-Feng Zhou, Xinhan Zhao,[...]. Oncotarget 2015
93
50


The emerging nanomedicine landscape.
Volker Wagner, Anwyn Dullaart, Anne-Katrin Bock, Axel Zweck. Nat Biotechnol 2006
749
50

Novel triple‑positive markers identified in human non‑small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics.
Nazilah Abdul Satar, Kamal Shaik Fakiruddin, Moon Nian Lim, Pooi Ling Mok, Norashikin Zakaria, Noor Atiqah Fakharuzi, Ahmad Zuhairi Abd Rahman, Zubaidah Zakaria, Badrul Hisham Yahaya, Puteri Baharuddin. Oncol Rep 2018
14
50

Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Marta Prieto-Vila, Ryou-U Takahashi, Wataru Usuba, Isaku Kohama, Takahiro Ochiya. Int J Mol Sci 2017
213
50

IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.
Soo Ok Lee, Xiaodong Yang, Shanzhou Duan, Ying Tsai, Laura R Strojny, Peter Keng, Yuhchyau Chen. Oncotarget 2016
54
50

ABCB5 gene amplification in human leukemia cells.
Natasha Y Frank, Markus H Frank. Leuk Res 2009
13
50

Defining lung cancer stem cells exosomal payload of miRNAs in clinical perspective.
Beatrice Aramini, Valentina Masciale, Khawaja Husnain Haider. World J Stem Cells 2020
2
50

Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients.
Tie Chen, Kun Yang, Jianhua Yu, Wentong Meng, Dandan Yuan, Feng Bi, Fang Liu, Jie Liu, Bing Dai, Xinzu Chen,[...]. Cell Res 2012
112
50

Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications.
Andreas Wicki, Dominik Witzigmann, Vimalkumar Balasubramanian, Jörg Huwyler. J Control Release 2015
788
50

Targeting the cancer initiating cell: the ultimate target for cancer therapy.
James A McCubrey, Linda S Steelman, Stephen L Abrams, Negin Misaghian, William H Chappell, Jorg Basecke, Ferdinando Nicoletti, Massimo Libra, Giovanni Ligresti, Francac Stivala,[...]. Curr Pharm Des 2012
35
50

The role of ATP binding cassette transporters in tissue defense and organ regeneration.
Miriam Huls, Frans G M Russel, Rosalinde Masereeuw. J Pharmacol Exp Ther 2009
116
50

Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion?
John Pawelek, Ashok Chakraborty, Rossita Lazova, Yesim Yilmaz, Dennis Cooper, Douglas Brash, Tamara Handerson. Contrib Microbiol 2006
26
50

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.
Prasanta K Dash, Howard E Gendelman, Upal Roy, Shantanu Balkundi, Yazen Alnouti, Rodney L Mosley, Harris A Gelbard, Joellyn McMillan, Santhi Gorantla, Larisa Y Poluektova. AIDS 2012
90
50

CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells?
Valentina Masciale, Giulia Grisendi, Federico Banchelli, Roberto D'Amico, Antonino Maiorana, Pamela Sighinolfi, Alessandro Stefani, Uliano Morandi, Massimo Dominici, Beatrice Aramini. Oncotarget 2020
2
50

Pleiotropic role of macrophage migration inhibitory factor in cancer.
Maheedhara R Guda, Matthew A Rashid, Swapna Asuthkar, Anvesh Jalasutram, John L Caniglia, Andrew J Tsung, Kiran K Velpula. Am J Cancer Res 2019
14
50

Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities.
Ana Teresa Pinto, Marta Laranjeiro Pinto, Ana Patrícia Cardoso, Cátia Monteiro, Marta Teixeira Pinto, André Filipe Maia, Patrícia Castro, Rita Figueira, Armanda Monteiro, Margarida Marques,[...]. Sci Rep 2016
89
50

CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling.
Renlun Huang, Shengqi Wang, Neng Wang, Yifeng Zheng, Jianfu Zhou, Bowen Yang, Xuan Wang, Juping Zhang, Lang Guo, Shusheng Wang,[...]. Cell Death Dis 2020
43
50

Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
Marine Chartrain, Joëlle Riond, Aline Stennevin, Isabelle Vandenberghe, Bruno Gomes, Laurence Lamant, Nicolas Meyer, Jean Edouard Gairin, Nicolas Guilbaud, Jean Philippe Annereau. PLoS One 2012
71
50

Folate-decorated nanogels for targeted therapy of ovarian cancer.
Natalia V Nukolova, Hardeep S Oberoi, Samuel M Cohen, Alexander V Kabanov, Tatiana K Bronich. Biomaterials 2011
141
50

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly, Omid C Farokhzad. Adv Drug Deliv Rev 2014
50

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients.
Hye Ryun Kim, Sang-Jun Ha, Min Hee Hong, Su Jin Heo, Yoon Woo Koh, Eun Chang Choi, Eun Kyung Kim, Kyoung Ho Pyo, Inkyung Jung, Daekwan Seo,[...]. Sci Rep 2016
146
50

Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency.
Melanie Werner-Klein, Ana Grujovic, Christoph Irlbeck, Milan Obradović, Martin Hoffmann, Huiqin Koerkel-Qu, Xin Lu, Steffi Treitschke, Cäcilia Köstler, Catherine Botteron,[...]. Nat Commun 2020
8
50

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Carola H Ries, Michael A Cannarile, Sabine Hoves, Jörg Benz, Katharina Wartha, Valeria Runza, Flora Rey-Giraud, Leon P Pradel, Friedrich Feuerhake, Irina Klaman,[...]. Cancer Cell 2014
705
50

The Role of CD44 and Cancer Stem Cells.
Liang Wang, Xiangsheng Zuo, Keping Xie, Daoyan Wei. Methods Mol Biol 2018
78
50

Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
James P Sullivan, Monica Spinola, Michael Dodge, Maria G Raso, Carmen Behrens, Boning Gao, Katja Schuster, Chunli Shao, Jill E Larsen, Laura A Sullivan,[...]. Cancer Res 2010
288
50

Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.
Laura Biddlestone-Thorpe, Nicola Marchi, Kathy Guo, Chaitali Ghosh, Damir Janigro, Kristoffer Valerie, Hu Yang. Adv Drug Deliv Rev 2012
64
50

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Vasiliki Pelekanou, Franz Villarroel-Espindola, Kurt A Schalper, Lajos Pusztai, David L Rimm. Breast Cancer Res 2018
40
50

Extracellular matrix: a dynamic microenvironment for stem cell niche.
Francesca Gattazzo, Anna Urciuolo, Paolo Bonaldo. Biochim Biophys Acta 2014
591
50

The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells.
Sang-Soo Kim, Antonina Rait, Farwah Rubab, Abhi K Rao, Michael C Kiritsy, Kathleen F Pirollo, Shangzi Wang, Louis M Weiner, Esther H Chang. Mol Ther 2014
34
50

Nanoparticle delivery of cancer drugs.
Andrew Z Wang, Robert Langer, Omid C Farokhzad. Annu Rev Med 2012
859
50

Immunosuppressive strategies that are mediated by tumor cells.
Gabriel A Rabinovich, Dmitry Gabrilovich, Eduardo M Sotomayor. Annu Rev Immunol 2007
50

Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche.
Cedric Blanpain, William E Lowry, Andrea Geoghegan, Lisa Polak, Elaine Fuchs. Cell 2004
956
50

Mechanisms of the epithelial-mesenchymal transition by TGF-beta.
Michael K Wendt, Tressa M Allington, William P Schiemann. Future Oncol 2009
218
50

Nanoparticle Interactions with the Tumor Microenvironment.
Yanyan Huai, Md Nazir Hossen, Stefan Wilhelm, Resham Bhattacharya, Priyabrata Mukherjee. Bioconjug Chem 2019
22
50

Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells.
D Kim, J Wang, S B Willingham, R Martin, G Wernig, I L Weissman. Leukemia 2012
123
50

The stemness phenotype model.
M H Cruz, A Sidén, G M Calaf, Z M Delwar, J S Yakisich. ISRN Oncol 2012
30
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.